The human genome and translational research: how much evidence is enough?
Multiple new genomic diagnostic tests are currently under development. Given the lack of an efficient translational infrastructure, it is not clear how, or whether, robust evidence for their clinical value will be generated.
Woodcock
Janet
J
Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA. Janet.woodcock@fda.hhs.gov
D019317:Evidence-Based Medicine; D036281:Genetic Research; D005820:Genetic Testing; D015894:Genome, Human; D006801:Humans; D010597:Pharmacogenetics